一种新的治疗选择，在哮喘和慢性闭合性肺病治疗低共付。治疗费用是否影响患者的依从性?

IF 0.2 Q4 ALLERGY

Alergologia Polska - Polish Journal of Allergology Pub Date : 2023-01-01 DOI:10.5114/pja.2023.131710

Przemysław Seweryn, Andrzej Emeryk, Maciej Kupczyk, Radosław Gawlik, Tomasz Dębowski, Grzegorz Sztaba, Rafał Pawliczak

{"title":"一种新的治疗选择，在哮喘和慢性闭合性肺病治疗低共付。治疗费用是否影响患者的依从性?","authors":"Przemysław Seweryn, Andrzej Emeryk, Maciej Kupczyk, Radosław Gawlik, Tomasz Dębowski, Grzegorz Sztaba, Rafał Pawliczak","doi":"10.5114/pja.2023.131710","DOIUrl":null,"url":null,"abstract":"AMA Seweryn P, Emeryk A, Kupczyk M, et al. Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):189-201. doi:10.5114/pja.2023.131710. APA Seweryn, P., Emeryk, A., Kupczyk, M., Gawlik, R., Dębowski, T., & Sztaba, G. et al. (2023). Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology, 10(3), 189-201. https://doi.org/10.5114/pja.2023.131710 Chicago Seweryn, Przemysław, Andrzej Emeryk, Maciej Kupczyk, Radosław Gawlik, Tomasz Dębowski, Grzegorz Sztaba, and Rafał Pawliczak. 2023. \"Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?\". Alergologia Polska - Polish Journal of Allergology 10 (3): 189-201. doi:10.5114/pja.2023.131710. Harvard Seweryn, P., Emeryk, A., Kupczyk, M., Gawlik, R., Dębowski, T., Sztaba, G., and Pawliczak, R. (2023). Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.189-201. https://doi.org/10.5114/pja.2023.131710 MLA Seweryn, Przemysław et al. \"Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?.\" Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 189-201. doi:10.5114/pja.2023.131710. Vancouver Seweryn P, Emeryk A, Kupczyk M, Gawlik R, Dębowski T, Sztaba G et al. Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):189-201. doi:10.5114/pja.2023.131710.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?\",\"authors\":\"Przemysław Seweryn, Andrzej Emeryk, Maciej Kupczyk, Radosław Gawlik, Tomasz Dębowski, Grzegorz Sztaba, Rafał Pawliczak\",\"doi\":\"10.5114/pja.2023.131710\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"AMA Seweryn P, Emeryk A, Kupczyk M, et al. Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):189-201. doi:10.5114/pja.2023.131710. APA Seweryn, P., Emeryk, A., Kupczyk, M., Gawlik, R., Dębowski, T., & Sztaba, G. et al. (2023). Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology, 10(3), 189-201. https://doi.org/10.5114/pja.2023.131710 Chicago Seweryn, Przemysław, Andrzej Emeryk, Maciej Kupczyk, Radosław Gawlik, Tomasz Dębowski, Grzegorz Sztaba, and Rafał Pawliczak. 2023. \\\"Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?\\\". Alergologia Polska - Polish Journal of Allergology 10 (3): 189-201. doi:10.5114/pja.2023.131710. Harvard Seweryn, P., Emeryk, A., Kupczyk, M., Gawlik, R., Dębowski, T., Sztaba, G., and Pawliczak, R. (2023). Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.189-201. https://doi.org/10.5114/pja.2023.131710 MLA Seweryn, Przemysław et al. \\\"Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?.\\\" Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 189-201. doi:10.5114/pja.2023.131710. Vancouver Seweryn P, Emeryk A, Kupczyk M, Gawlik R, Dębowski T, Sztaba G et al. Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):189-201. doi:10.5114/pja.2023.131710.\",\"PeriodicalId\":7469,\"journal\":{\"name\":\"Alergologia Polska - Polish Journal of Allergology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alergologia Polska - Polish Journal of Allergology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/pja.2023.131710\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alergologia Polska - Polish Journal of Allergology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/pja.2023.131710","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

摘要

张建军，张建军，张建军，等。一种新的治疗选择，在哮喘和慢性闭合性肺病治疗低共付。治疗费用是否影响患者的依从性?波兰过敏症杂志。2023;10(3):189-201。doi: 10.5114 / pja.2023.131710。APA Seweryn, P.， Emeryk, A.， Kupczyk, M.， Gawlik, R.， Dębowski, T.， & Sztaba, G.等(2023)。一种新的治疗选择，在哮喘和慢性闭合性肺病治疗低共付。治疗费用是否影响患者的依从性?波兰过敏症-波兰过敏症杂志，10(3)，189-201。https://doi.org/10.5114/pja.2023.131710 Chicago Seweryn, Przemysław, Andrzej Emeryk, Maciej Kupczyk, Radosław Gawlik, Tomasz Dębowski, Grzegorz Sztaba, rafazov Pawliczak. 2023。“Formodual——一种低共付的哮喘和慢性闭合性肺病治疗的新选择。治疗费用是否影响患者的依从性?波兰过敏症杂志10(3):189-201。doi: 10.5114 / pja.2023.131710。Harvard Seweryn, P.， Emeryk, A.， Kupczyk, M.， Gawlik, R.， Dębowski, T.， Sztaba, G.，和Pawliczak, R.(2023)。一种新的治疗选择，在哮喘和慢性闭合性肺病治疗低共付。治疗费用是否影响患者的依从性?波兰过敏学杂志，10(3)，pp.189-201。https://doi.org/10.5114/pja.2023.131710 MLA Seweryn, Przemysław等。“Formodual——一种低共付的哮喘和慢性闭合性肺病治疗的新选择。治疗费用是否影响患者的依从性?”波兰过敏学杂志，第10卷，第10期。3, 2023，页189-201。doi: 10.5114 / pja.2023.131710。王晓明，王晓明，王晓明，等。一种新的治疗选择，在哮喘和慢性闭合性肺病治疗低共付。治疗费用是否影响患者的依从性?波兰过敏症杂志。2023;10(3):189-201。doi: 10.5114 / pja.2023.131710。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?

AMA Seweryn P, Emeryk A, Kupczyk M, et al. Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):189-201. doi:10.5114/pja.2023.131710. APA Seweryn, P., Emeryk, A., Kupczyk, M., Gawlik, R., Dębowski, T., & Sztaba, G. et al. (2023). Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology, 10(3), 189-201. https://doi.org/10.5114/pja.2023.131710 Chicago Seweryn, Przemysław, Andrzej Emeryk, Maciej Kupczyk, Radosław Gawlik, Tomasz Dębowski, Grzegorz Sztaba, and Rafał Pawliczak. 2023. "Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?". Alergologia Polska - Polish Journal of Allergology 10 (3): 189-201. doi:10.5114/pja.2023.131710. Harvard Seweryn, P., Emeryk, A., Kupczyk, M., Gawlik, R., Dębowski, T., Sztaba, G., and Pawliczak, R. (2023). Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology, 10(3), pp.189-201. https://doi.org/10.5114/pja.2023.131710 MLA Seweryn, Przemysław et al. "Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?." Alergologia Polska - Polish Journal of Allergology, vol. 10, no. 3, 2023, pp. 189-201. doi:10.5114/pja.2023.131710. Vancouver Seweryn P, Emeryk A, Kupczyk M, Gawlik R, Dębowski T, Sztaba G et al. Formodual – a new therapeutic option in asthma and chronic obturative pulmonary disease treatment with low copayment. Does the therapy cost influence patients’ compliance?. Alergologia Polska - Polish Journal of Allergology. 2023;10(3):189-201. doi:10.5114/pja.2023.131710.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Alergologia Polska - Polish Journal of Allergology ALLERGY-

自引率

50.00%

发文量

期刊介绍： Alergologia Polska - Polish Journal of Allergology is aimed mainly at allergologists, but also medical doctors working in related fields, such as otolaryngology, pulmonology, and dermatology. The main goal of the journal is to ensure rapid publication of important research papers and interesting case studies from the following areas: allergology, diagnostics, therapy of allergic diseases, in particular in the area of immunotherapy, rhinitis, asthma. The Editorial Board accepts for publication original papers, case studies and letters to the Editor. We also publish review articles (both commissioned and those agreed upon with the Editor-in-Chief), articles dealing with standards of medical practice, as well as special issues. The journal is published quarterly. We guarantee short review times (up to two weeks) and immediate publication on-line upon Editor acceptance.